However, treatment with adenovirus early region 1A (E1A) or adenovirus-E1A therapy markedly decreased tumor formation in mice and enhanced sensitivity to etoposide and adriamycin by downregulating HER2 and upregulating topoisomerase IIα (Zhou et al., 2001; Zhou et al., 2002). Here, DHTKD1 is linked to neoplasm.